Materias dentro de su búsqueda.
Mostrando 23,961 - 23,980 Resultados de 24,879 Para Buscar '".eu"', tiempo de consulta: 0.62s Limitar resultados
  1. 23961
    “…VIRTUAL SLIDES: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/1348836442160205.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Expression of HNF-1β in cervical carcinomas: an immunohistochemical study of 155 cases
  2. 23962
    “…VIRTUAL SLIDES: The virtual slides for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/1465801416161912…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Clinicopathologic features of plasmablastic lymphoma: Single-center series of 8 cases from Saudi Arabia
  3. 23963
    “…BACKGROUND: Combination of the inhaled long-acting muscarinic antagonist umeclidinium (UMEC; GSK573719) with the long-acting β(2)-agonist vilanterol (VI) is an approved maintenance treatment for COPD in the US and EU. We compared the efficacy and safety of UMEC/VI with placebo in patients with COPD of Asian ancestry. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Efficacy and safety of once-daily inhaled umeclidinium/vilanterol in Asian patients with COPD: results from a randomized, placebo-controlled study
  4. 23964
    “…This would allow an analytical sensitivity (AS) of 0.0001 fibres per millilitre (f ml(−1)) to be achieved, which is 1000 times lower than the EU and UK workplace control limit of 0.1 f ml(−1). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Airborne Asbestos Exposures from Warm Air Heating Systems in Schools
  5. 23965
    “…BACKGROUND: Fluticasone furoate (FF)/vilanterol (VI) is a once daily (OD) inhaled corticosteroid/long-acting β(2)-agonist combination asthma therapy approved in Japan and the EU. FF/VI efficacy and safety data from asthma studies including patients in East Asia were evaluated to assess ethnic sensitivity. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Ethnic sensitivity assessment of fluticasone furoate/vilanterol in East Asian asthma patients from randomized double-blind multicentre Phase IIb/III trials
  6. 23966
    “…We searched (to 2 November 2015) CENTRAL, Medline, Embase, CINAHL, PubMed, LILACS, NHSBT Transfusion Evidence Library, ClinicalTrials.gov, WHO International Clinical Trials Registry Platform, ISRCTN Register, and EU Clinical Trials Register. Authors were contacted for data whenever possible. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Effect of restrictive versus liberal transfusion strategies on outcomes in patients with cardiovascular disease in a non-cardiac surgery setting: systematic review and meta-analysis
  7. 23967
    “…METHODS: Eurolight was a cross-sectional survey sampling from the adult populations (18–65 years) of 10 EU countries. We used data from six. The questionnaire included headache-diagnostic questions based on ICHD-II, the Headache-Attributed Lost Time (HALT) questionnaire, and HADS for depression and anxiety. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Headache, depression and anxiety: associations in the Eurolight project
  8. 23968
    “…Although limited by a small sample size, our study represents a first attempt at analysing such data in six EU countries. Our findings should encourage the conduction of further studies on this topic, long-term and large sample-sized studies, ideally conducted in the general population.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Usage of Plant Food Supplements (PFS) for weight control in six European countries: results from the PlantLIBRA PFS Consumer Survey 2011-2012
  9. 23969
    “…TRIAL REGISTRATION: This trial is registered at ClinicalTrials.gov (NCT01483144; November 21, 2011) and the EU Clinical Trials Register(EudraCT 2012-000427-41; May 15, 2014). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Efficacy and safety of eflornithine (CPP-1X)/sulindac combination therapy versus each as monotherapy in patients with familial adenomatous polyposis (FAP): design and rationale of a randomized, double-blind, Phase III trial
  10. 23970
    por Forde, Natalie J., Kanaan, Ahmad S., Widomska, Joanna, Padmanabhuni, Shanmukha S., Nespoli, Ester, Alexander, John, Rodriguez Arranz, Juan I., Fan, Siyan, Houssari, Rayan, Nawaz, Muhammad S., Rizzo, Francesca, Pagliaroli, Luca, Zilhäo, Nuno R., Aranyi, Tamas, Barta, Csaba, Boeckers, Tobias M., Boomsma, Dorret I., Buisman, Wim R., Buitelaar, Jan K., Cath, Danielle, Dietrich, Andrea, Driessen, Nicole, Drineas, Petros, Dunlap, Michelle, Gerasch, Sarah, Glennon, Jeffrey, Hengerer, Bastian, van den Heuvel, Odile A., Jespersgaard, Cathrine, Möller, Harald E., Müller-Vahl, Kirsten R., Openneer, Thaïra J. C., Poelmans, Geert, Pouwels, Petra J. W., Scharf, Jeremiah M., Stefansson, Hreinn, Tümer, Zeynep, Veltman, Dick J., van der Werf, Ysbrand D., Hoekstra, Pieter J., Ludolph, Andrea, Paschou, Peristera
    Publicado 2016
    “…TS-EUROTRAIN (FP7-PEOPLE-2012-ITN, Grant Agr.No. 316978) is a Marie Curie Initial Training Network (http://ts-eurotrain.eu) that aims to elucidate the complex etiology of the onset and clinical course of GTS, investigate the neurobiological underpinnings of GTS and related disorders, translate research findings into clinical applications, and establish a pan-European infrastructure for the study of GTS. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    TS-EUROTRAIN: A European-Wide Investigation and Training Network on the Etiology and Pathophysiology of Gilles de la Tourette Syndrome
  11. 23971
    “…CONCLUSIONS: This study of TP300 showed good drug tolerability but it failed to demonstrate sufficient efficacy as measured by radiological response. TRIAL REGISTRATION: EU-CTR 2009-012097-12 2009-09-03…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Phase II study of TP300 in patients with advanced gastric or gastro-oesophageal junction adenocarcinoma
  12. 23972
    “…Six agritourisms outbuilding slaughterhouses – EU-approved – were investigated. General and hygiene requirements of outbuilding slaughterhouses and animal welfare indicators of 68 piglets and 5 finishing pigs were evaluated by mean of a checklist. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Hygiene and Welfare Evaluation of Pigs Slaughtered in Agritourisms
  13. 23973
    “…TRIAL REGISTRATION: EWO-ISO-2014/1, EudraCT 2014-001863-11; Date of registration: 29 APR 2014; Detail information web link: https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001863-11/results ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12879-016-1965-5) contains supplementary material, which is available to authorized users.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Inosine pranobex is safe and effective for the treatment of subjects with confirmed acute respiratory viral infections: analysis and subgroup analysis from a Phase 4, randomised, placebo-controlled, double-blind study
  14. 23974
    “…TRIAL REGISTRATION: The trial was prospectively registered at www.clinicaltrialsregister.eu (EudraCT no. 2015–000460–34) and at https://www.germanctr.de (DRKS-ID: DRKS00009733).…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Effects of acetyl-DL-leucine on cerebellar ataxia (ALCAT trial): study protocol for a multicenter, multinational, randomized, double-blind, placebo-controlled, crossover phase III trial
  15. 23975
    “…BACKGROUND AND OBJECTIVE: Once-daily oral fingolimod is approved in the EU as escalation treatment for adult patients with highly active relapsing multiple sclerosis (MS). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Real-World Outcomes in Fingolimod-Treated Patients with Multiple Sclerosis in the Czech Republic: Results from the 12-Month GOLEMS Study
  16. 23976
    “…CONCLUSIONS: The prevalence of LA-MRSA-positive pig farms in Poland has increased considerably since 2008, when the first MRSA EU baseline survey was conducted in Europe. On Polish pig farms CC398 of the animal clade predominates, this being also reflected in the prevalence of CC398 nasal carriage in farmers and veterinarians. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Livestock-associated Staphylococcus aureus on Polish pig farms
  17. 23977
    “…The {Fe(4)Ln(2)}-type compounds [Fe(4)Ln(2)(O(2)CCMe(3))(6)(N(3))(4)(Htea)(4)]·2(EtOH), Ln = Dy (1a), Er (1b), Ho (1c); [Fe(4)Tb(2)(O(2)CCMe(3))(6)(N(3))(4)(Htea)(4)] (1d); [Fe(4)Ln(2)(O(2)CCMe(3))(6)(N(3))(4)(Htea)(4)]·2(CH(2)Cl(2)), Ln = Dy (2a), Er (2b); [Fe(4)Ln(2)(O(2)CCMe(3))(4)(N(3))(6)(Htea)(4)]·2(EtOH)·2(CH(2)Cl(2)), Ln = Dy (3a), Er (3b) and the {Fe(18)M(6)}-type compounds [Fe(18)M(6)(O(2)CCHMe(2))(12)(Htea)(18)(tea)(6)(N(3))(6)]·n(solvent), M = Dy (4, 4a), Gd (5), Tb (6), Ho (7), Sm (8), Eu (9), and Y (10) form in ca. 20–40% yields in direct reaction of trinuclear Fe(III) pivalate or isobutyrate clusters, lanthanide/yttrium nitrates, and bridging triethanolamine (H(3)tea) and azide ligands in different solvents: EtOH for the smaller {Fe(4)Ln(2)} wheels and MeOH/MeCN or MeOH/EtOH for the larger {Fe(18)M(6)} wheels. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Ultralarge 3d/4f Coordination Wheels: From Carboxylate/Amino Alcohol-Supported {Fe(4)Ln(2)} to {Fe(18)Ln(6)} Rings
  18. 23978
    “…Based on the SPARK trial results, sapropterin has received EU approval to treat patients <4 years with BH(4)-responsive phenylketonuria. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Efficacy, safety and population pharmacokinetics of sapropterin in PKU patients <4 years: results from the SPARK open-label, multicentre, randomized phase IIIb trial
  19. 23979
    “…METHODS: Data were collected from a questionnaire survey of nurses in a sample of English hospitals, conducted as part of the RN4CAST study, an EU 7(th) Framework funded study. The sample comprised 31 NHS acute hospital Trusts from 401 wards, in 46 acute hospital sites. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Cross-sectional examination of the association between shift length and hospital nurses job satisfaction and nurse reported quality measures
  20. 23980
    “…In patients with mild to severe gastrointestinal problems, prucalopride may be effective in treating dismotility symptoms, increasing the number of complete bowel movements and improving bowel transit, reducing reflux disease and bloating. TRIAL REGISTRATION: EU Clinical Trial Registry, EudraCT2012-005348-92. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Preliminary safety and efficacy profile of prucalopride in the treatment of systemic sclerosis (SSc)-related intestinal involvement: results from the open label cross-over PROGASS study
Herramientas de búsqueda: RSS